Warts Clinical Trial
Official title:
New Formulation of Salicylate to Improve Treatment of Common Skin Warts
Plantar warts on the sole of the foot are among the most common warts seen in podiatry
clinics. Some patients are readily cured by simple standard of care treatments that include
wart debridement (trimming or excision) and application of 17% salicylate (commercially
known as Compound W)or by other treatments that may be painful and affect mobility. No
treatment is consistently effective and most patients fail treatment multiple times.
Ethyl pyruvate (EP)is a common food additive noted to be 'generally regarded as safe' that
may improve the activity of salicylate in wart treatment by improving the ability to
penetrate and/or persist in the skin. The use of 17% salicylate with the addition of EP may
improve cures of common foot plantar warts in subjects who also be receiving other
standard-of-care treatment.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01757392 -
Candin Safety & Efficacy Study for the Treatment of Warts
|
Phase 2 | |
| Completed |
NCT00973856 -
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
|
N/A | |
| Completed |
NCT02902822 -
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
|
N/A | |
| Withdrawn |
NCT00546611 -
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
|
Phase 1 | |
| Completed |
NCT00117871 -
Study With a Topical Gel to Treat Common Warts in Adults
|
Phase 2 | |
| Completed |
NCT04278573 -
Intralesional Vitamin D Injection for Treatment of Common Warts
|
Phase 2 | |
| Completed |
NCT02231879 -
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
|
Phase 2/Phase 3 | |
| Completed |
NCT06309420 -
Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts
|
N/A | |
| Not yet recruiting |
NCT05616078 -
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
|
N/A | |
| Not yet recruiting |
NCT05617950 -
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
|
N/A | |
| Active, not recruiting |
NCT00254280 -
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial
|
N/A | |
| Completed |
NCT04781244 -
Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment
|
N/A | |
| Completed |
NCT01101750 -
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
|
Phase 4 | |
| Completed |
NCT03487549 -
Cantharidin and Occlusion in Verruca Epithelium
|
Phase 2 | |
| Recruiting |
NCT05625633 -
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
|
Phase 2/Phase 3 | |
| Completed |
NCT02393417 -
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
|
Phase 2 | |
| Completed |
NCT01808443 -
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
|
N/A | |
| Completed |
NCT00116675 -
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
|
Phase 2 | |
| Completed |
NCT00116662 -
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
|
Phase 2 | |
| Completed |
NCT00114920 -
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
|
Phase 2 |